首页 > 最新文献

Indian Journal of Pharmacology最新文献

英文 中文
Plasma drug concentration resulting from body surface area-based dosage. 基于体表面积的剂量产生的血浆药物浓度。
IF 2.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-09-01 DOI: 10.4103/ijp.ijp_470_23
Heng Wang, Song Xue
{"title":"Plasma drug concentration resulting from body surface area-based dosage.","authors":"Heng Wang, Song Xue","doi":"10.4103/ijp.ijp_470_23","DOIUrl":"10.4103/ijp.ijp_470_23","url":null,"abstract":"","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"55 5","pages":"340"},"PeriodicalIF":2.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10751524/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71481109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genomic biomarkers: Unveiling the potential for precise cancer therapy response. 基因组生物标志物:揭示精确癌症治疗反应的潜力。
IF 2.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-01 DOI: 10.4103/ijp.ijp_442_23
Gurjeet Kaur, Paras Pahwa, Ajay Prakash, Bikash Medhi
{"title":"Genomic biomarkers: Unveiling the potential for precise cancer therapy response.","authors":"Gurjeet Kaur, Paras Pahwa, Ajay Prakash, Bikash Medhi","doi":"10.4103/ijp.ijp_442_23","DOIUrl":"10.4103/ijp.ijp_442_23","url":null,"abstract":"","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"55 4","pages":"213-215"},"PeriodicalIF":2.4,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657619/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41123028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case series on tofacitinib-induced weight gain. 托法替尼诱导体重增加的病例系列。
IF 2.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-01 DOI: 10.4103/ijp.ijp_158_23
Kanisha Shah, Dhaiwat Shukla, Manish Patel, Supriya Malhotra

Janus kinase inhibitor tofacitinib belongs to a group of targeted synthetic disease-modifying anti-rheumatic drugs, also known as small molecule inhibitors. They are oral drugs with a novel strategy to treat inflammatory diseases. The major concern with the use of these drugs is a high risk for infections and other potential side effects. Here, we have focused on reporting one of the rare side effects of tofacitinib, weight gain. We have reported six cases of tofacitinib-induced weight gain in patients of ankylosing spondylitis, rheumatoid arthritis, and vasculitis.

Janus激酶抑制剂托法替尼属于一组靶向合成的疾病修饰抗风湿药物,也称为小分子抑制剂。它们是口服药物,具有治疗炎症性疾病的新策略。使用这些药物的主要问题是感染和其他潜在副作用的高风险。在这里,我们重点报道了托法替尼的一种罕见副作用,即体重增加。我们报道了6例托法替尼诱导强直性脊柱炎、类风湿性关节炎和血管炎患者体重增加的病例。
{"title":"A case series on tofacitinib-induced weight gain.","authors":"Kanisha Shah, Dhaiwat Shukla, Manish Patel, Supriya Malhotra","doi":"10.4103/ijp.ijp_158_23","DOIUrl":"10.4103/ijp.ijp_158_23","url":null,"abstract":"<p><p>Janus kinase inhibitor tofacitinib belongs to a group of targeted synthetic disease-modifying anti-rheumatic drugs, also known as small molecule inhibitors. They are oral drugs with a novel strategy to treat inflammatory diseases. The major concern with the use of these drugs is a high risk for infections and other potential side effects. Here, we have focused on reporting one of the rare side effects of tofacitinib, weight gain. We have reported six cases of tofacitinib-induced weight gain in patients of ankylosing spondylitis, rheumatoid arthritis, and vasculitis.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"55 4","pages":"263-265"},"PeriodicalIF":2.4,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657621/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41100326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microteaching: Overview and examination evaluation. 微格教学:概述和考试评估。
IF 2.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-01 DOI: 10.4103/ijp.ijp_912_21
Pugazhenthan Thangaraju, Bikash Medhi

Nearly all teachers are forced into teaching and gain experience through time, but many do not feel adequately prepared for their fieldwork in their training program. Only solution which helps teachers and students is to connect theory to practice by microteaching. It is a strategy for acquiring teaching abilities on a smaller scale, in which teachers may practice previously learned skills as well as acquire new ones. The efficiency of microteaching may be predicted using feedback from participants. While preservice instructors benefit from microteaching and students themselves find it helpful, academics have not yet looked closely at the assignment itself to determine precisely what microteaching entails. As a result, this study aids in learning more about the interactional aspects of microteaching and the effect of it in both teachers and students.

几乎所有的教师都被迫从事教学,并通过时间积累经验,但许多教师在培训计划中没有为实地工作做好充分准备。只有通过微格教学把理论和实践联系起来,才能帮助教师和学生。这是一种在较小规模上获得教学能力的策略,教师可以练习以前学到的技能,也可以获得新的技能。可以使用来自参与者的反馈来预测微格教学的效率。虽然职前教师从微格教学中受益,学生自己也觉得这很有帮助,但学者们还没有仔细研究作业本身,以确定微格教学的具体内容。因此,本研究有助于更多地了解微格教学的互动方面及其对教师和学生的影响。
{"title":"Microteaching: Overview and examination evaluation.","authors":"Pugazhenthan Thangaraju, Bikash Medhi","doi":"10.4103/ijp.ijp_912_21","DOIUrl":"10.4103/ijp.ijp_912_21","url":null,"abstract":"<p><p>Nearly all teachers are forced into teaching and gain experience through time, but many do not feel adequately prepared for their fieldwork in their training program. Only solution which helps teachers and students is to connect theory to practice by microteaching. It is a strategy for acquiring teaching abilities on a smaller scale, in which teachers may practice previously learned skills as well as acquire new ones. The efficiency of microteaching may be predicted using feedback from participants. While preservice instructors benefit from microteaching and students themselves find it helpful, academics have not yet looked closely at the assignment itself to determine precisely what microteaching entails. As a result, this study aids in learning more about the interactional aspects of microteaching and the effect of it in both teachers and students.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"55 4","pages":"257-262"},"PeriodicalIF":2.4,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657622/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41109039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Testing the knowledge and interpretation skills of ChatGPT in pharmacology examination of phase II MBBS. 在II期MBBS药理学考试中测试ChatGPT的知识和解释技能。
IF 2.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-01 DOI: 10.4103/ijp.ijp_188_23
Anitha Elango, Neevedha Kannan, Isswariya Anandan, Krishna Mohan Surapaneni
{"title":"Testing the knowledge and interpretation skills of ChatGPT in pharmacology examination of phase II MBBS.","authors":"Anitha Elango, Neevedha Kannan, Isswariya Anandan, Krishna Mohan Surapaneni","doi":"10.4103/ijp.ijp_188_23","DOIUrl":"10.4103/ijp.ijp_188_23","url":null,"abstract":"","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"55 4","pages":"266-267"},"PeriodicalIF":2.4,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657626/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41122080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fixed drug eruption - Experience from a tertiary care center in Uttarakhand. 修复药疹-北阿坎德邦三级护理中心的经验。
IF 2.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-01 DOI: 10.4103/ijp.ijp_177_23
Neirita Hazarika, Puneet Dhamija, Amrita Upadhyaya, Manisha Rauthan
{"title":"Fixed drug eruption - Experience from a tertiary care center in Uttarakhand.","authors":"Neirita Hazarika, Puneet Dhamija, Amrita Upadhyaya, Manisha Rauthan","doi":"10.4103/ijp.ijp_177_23","DOIUrl":"10.4103/ijp.ijp_177_23","url":null,"abstract":"","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"55 4","pages":"270-271"},"PeriodicalIF":2.4,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657620/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41109022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of vascular endothelial growth factor in tuberculous meningitis: A prospective study from a tertiary care center in North India. 血管内皮生长因子在结核性脑膜炎中的作用:来自北印度一家三级护理中心的前瞻性研究。
IF 2.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-01 DOI: 10.4103/ijp.ijp_743_22
Devesh Kumar, Deependra Singh, Tanish Modi, Riya Sharma, Anand Keshav Awasthy, Ritu Shree, Manoj Kumar Goyal, Dhawal Narang, Siddharth Chand, Sameer Vyas, Kusum Sharma, Navneet Sharma, Rudresh Gowda, Abeer Goel, Rajeev Ranjan, Manish Modi

Introduction: The status of vascular endothelial-derived growth factor (VEGF) in the pathogenesis of tuberculous meningitis (TBM) remains far from clear. We prospectively evaluated the role of serum and cerebrospinal fluid (CSF) VEGF in TBM.

Patients and methods: This prospective study was conducted at a tertiary care center in North India from January 2018 to June 2019. Consecutive drug-naive patients (n = 82) of TBM diagnosed on the basis of modified Ahuja's criteria were included in the study. The results were compared with 49 control subjects (n = 49). Serum and CSF VEGF were done in all the cases and controls. Follow-up serum VEGF levels were done in 34 patients after 3 months of completion of antitubercular therapy. The VEGF levels were estimated using the human VEGF enzyme-linked immunosorbent assay kit.

Results: The mean age was 29.9 ± 13.1 years. The study group consisted of 33 (40.2%) men and 49 (59.8%) women. BACTEC MGIT960 was positive in 15 (18%) patients while multiplex tuberculosis polymerase chain reaction was positive in 73 (89%) patients. Levels of VEGF in serum and CSF of TBM patients were not elevated when compared to controls. There was no association between final outcome in TBM and decrease in serum levels of VEGF at follow-up.

Conclusion: VEGF may not be playing a significant role in the pathogenesis of TBM. Future studies with larger sample size may clarify the status of VEGF further in TBM.

引言:血管内皮衍生生长因子(VEGF)在结核性脑膜炎(TBM)发病机制中的地位尚不清楚。我们前瞻性评估了血清和脑脊液(CSF)VEGF在TBM中的作用。患者和方法:这项前瞻性研究于2018年1月至2019年6月在北印度的一家三级护理中心进行。根据改良的Ahuja标准诊断的连续未服用药物的TBM患者(n=82)被纳入研究。将结果与49名对照受试者(n=49)进行比较。所有病例和对照组均进行血清和CSF VEGF检测。34名患者在完成抗结核治疗3个月后进行了血清VEGF水平的随访。使用人VEGF酶联免疫吸附测定试剂盒估计VEGF水平。结果:平均年龄29.9±13.1岁。研究组包括33名(40.2%)男性和49名(59.8%)女性。BACTEC MGIT960在15例(18%)患者中呈阳性,而多重结核聚合酶链反应在73例(89%)患者中阳性。与对照组相比,TBM患者血清和CSF中的VEGF水平没有升高。TBM的最终结果与随访时血清VEGF水平的下降之间没有关联。结论:VEGF可能在TBM的发病机制中没有发挥重要作用。未来更大样本量的研究可能会进一步阐明VEGF在TBM中的地位。
{"title":"Role of vascular endothelial growth factor in tuberculous meningitis: A prospective study from a tertiary care center in North India.","authors":"Devesh Kumar, Deependra Singh, Tanish Modi, Riya Sharma, Anand Keshav Awasthy, Ritu Shree, Manoj Kumar Goyal, Dhawal Narang, Siddharth Chand, Sameer Vyas, Kusum Sharma, Navneet Sharma, Rudresh Gowda, Abeer Goel, Rajeev Ranjan, Manish Modi","doi":"10.4103/ijp.ijp_743_22","DOIUrl":"10.4103/ijp.ijp_743_22","url":null,"abstract":"<p><strong>Introduction: </strong>The status of vascular endothelial-derived growth factor (VEGF) in the pathogenesis of tuberculous meningitis (TBM) remains far from clear. We prospectively evaluated the role of serum and cerebrospinal fluid (CSF) VEGF in TBM.</p><p><strong>Patients and methods: </strong>This prospective study was conducted at a tertiary care center in North India from January 2018 to June 2019. Consecutive drug-naive patients (n = 82) of TBM diagnosed on the basis of modified Ahuja's criteria were included in the study. The results were compared with 49 control subjects (n = 49). Serum and CSF VEGF were done in all the cases and controls. Follow-up serum VEGF levels were done in 34 patients after 3 months of completion of antitubercular therapy. The VEGF levels were estimated using the human VEGF enzyme-linked immunosorbent assay kit.</p><p><strong>Results: </strong>The mean age was 29.9 ± 13.1 years. The study group consisted of 33 (40.2%) men and 49 (59.8%) women. BACTEC MGIT960 was positive in 15 (18%) patients while multiplex tuberculosis polymerase chain reaction was positive in 73 (89%) patients. Levels of VEGF in serum and CSF of TBM patients were not elevated when compared to controls. There was no association between final outcome in TBM and decrease in serum levels of VEGF at follow-up.</p><p><strong>Conclusion: </strong>VEGF may not be playing a significant role in the pathogenesis of TBM. Future studies with larger sample size may clarify the status of VEGF further in TBM.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"55 4","pages":"216-222"},"PeriodicalIF":2.4,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657616/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41123029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Citicoline on the Barthel Index: Severe and moderate brain injury. Citicoline对Barthel指数的影响:严重和中度脑损伤。
IF 2.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-01 DOI: 10.4103/ijp.ijp_570_21
Mehdi Mahmoodkhani, Bahram Aminmansour, Mehdi Shafiei, Mohammadreza Hasas, Donya Sheibani Tehrani

Introduction: Traumatic brain injury (TBI) is a paramount factor in mortality and morbidity. The clinical trials conducted to investigate the efficacy of neuroprotective agents, such as citicoline, as a therapeutic alternative for TBI have presented divergent findings. Therefore, this study aimed to evaluate and compare citicoline's effect on the Barthel Index in patients with severe and moderate brain injury.

Materials and methods: The study is a randomized clinical trial. Patients in the case group (35 patients) were treated with citicoline and the control group (34 patients) received a placebo. Data were analyzed using SPSS 16 software.

Results: The results showed that changes in the Glasgow Coma Scale, changes in quadriceps muscle force score, Barthel Index score changes, achieving the status without intubation, and spontaneous breathing in patients treated with citicoline were not a statistically significant difference in the two groups (P > 0.05).

Conclusion: Findings revealed that citicoline did not impact the recovery process of severe and moderate TBI patients.

引言:创伤性脑损伤(TBI)是死亡率和发病率的重要因素。为研究胞磷胆碱等神经保护剂作为TBI治疗替代品的疗效而进行的临床试验呈现出不同的结果。因此,本研究旨在评估和比较胞磷胆碱对严重和中度脑损伤患者Barthel指数的影响。材料与方法:本研究为随机临床试验。病例组(35例)接受胞磷胆碱治疗,对照组(34例)接受安慰剂治疗。数据分析采用SPSS 16软件。结果:格拉斯哥昏迷量表变化、股四头肌肌力评分变化、Barthel指数评分变化,达到无插管状态,结论:胞磷胆碱对重、中度TBI患者的恢复过程无明显影响。
{"title":"Citicoline on the Barthel Index: Severe and moderate brain injury.","authors":"Mehdi Mahmoodkhani, Bahram Aminmansour, Mehdi Shafiei, Mohammadreza Hasas, Donya Sheibani Tehrani","doi":"10.4103/ijp.ijp_570_21","DOIUrl":"10.4103/ijp.ijp_570_21","url":null,"abstract":"<p><strong>Introduction: </strong>Traumatic brain injury (TBI) is a paramount factor in mortality and morbidity. The clinical trials conducted to investigate the efficacy of neuroprotective agents, such as citicoline, as a therapeutic alternative for TBI have presented divergent findings. Therefore, this study aimed to evaluate and compare citicoline's effect on the Barthel Index in patients with severe and moderate brain injury.</p><p><strong>Materials and methods: </strong>The study is a randomized clinical trial. Patients in the case group (35 patients) were treated with citicoline and the control group (34 patients) received a placebo. Data were analyzed using SPSS 16 software.</p><p><strong>Results: </strong>The results showed that changes in the Glasgow Coma Scale, changes in quadriceps muscle force score, Barthel Index score changes, achieving the status without intubation, and spontaneous breathing in patients treated with citicoline were not a statistically significant difference in the two groups (P > 0.05).</p><p><strong>Conclusion: </strong>Findings revealed that citicoline did not impact the recovery process of severe and moderate TBI patients.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"55 4","pages":"223-228"},"PeriodicalIF":2.4,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657618/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41122079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacovigilance in the medical education: In UG curriculum where do we stand? What can be done? 医学教育中的药物警戒:在UG课程中,我们的立场是什么?能做些什么?
IF 2.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-01 DOI: 10.4103/ijp.ijp_145_23
Shiva Murthy Nanjundappa, Pratibha Durgesh Nadig, M K Jayanti, R M Veena, G N Manjunath
{"title":"Pharmacovigilance in the medical education: In UG curriculum where do we stand? What can be done?","authors":"Shiva Murthy Nanjundappa, Pratibha Durgesh Nadig, M K Jayanti, R M Veena, G N Manjunath","doi":"10.4103/ijp.ijp_145_23","DOIUrl":"10.4103/ijp.ijp_145_23","url":null,"abstract":"","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"55 4","pages":"268-269"},"PeriodicalIF":2.4,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657627/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41138649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential use of Balanophora latisepala (V. Tiegh.) Lec. extract for the treatment of diabetes. latisepala Balanophora(V.Tiegh.)Lec的潜在用途。用于治疗糖尿病的提取物。
IF 2.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-01 DOI: 10.4103/ijp.ijp_253_23
Nguyen Trong Hong Phuc, Nguyen Thi Yen Lan, Nguyen Van Ay

Introduction: Balanophora latisepala (BL) is a chlorophyll-free and obligate parasitic plant found across mountainous areas of An Giang, Vietnam. This study was conducted to evaluate the effectiveness of extracts from BL, herbs mentioned in many traditional medicines in the treatment of diabetes, on laboratory mice.

Materials and methods: The effects of BL aqueous, methanol, and ethanol extracts on the blood glucose levels, hematological indices, liver enzymes, and pancreatic tissue structure of normal, glucose-tolerant mice, and diabetic mice treated with streptozotocin (STZ) were assessed. Mice were orally administered extracts at a concentration of 500 mg/kg.

Results and discussion: The aqueous and ethanol extracts did not affect the blood glucose levels of healthy and glucose-tolerant mice (P > 0.05). The methanol extract reduced the blood glucose of healthy mice (P < 0.05) but did not affect the blood glucose of glucose-tolerant mice 3 h after administration (P > 0.05). When taking the methanol and ethanol extracts, the diabetic mice experienced a 45.67% and a 40.33% decrease in blood glucose levels after 21 days of research, respectively. Aqueous extract and gliclazide (10 mg/kg) showed no effect on reducing blood glucose levels in diabetic mice over the 21 days of the study. Both methanol and ethanol extracts were effective in regulating liver enzyme levels in diabetic mice. In both untreated and treated diabetic mice, pancreatic islet structures were degraded with the appearance of gaps resulting from β-cell degeneration.

Conclusion: This implies that ethanol extracts have potential applications in regulating blood glucose levels.

简介:宽唇Balanophora latisepala(BL)是一种不含叶绿素的专性寄生植物,分布在越南安江山区。本研究旨在评估BL提取物(许多传统药物中提到的草药)对实验小鼠治疗糖尿病的有效性。材料和方法:评估BL水提取物、甲醇提取物和乙醇提取物对链脲佐菌素(STZ)治疗的正常、耐糖小鼠和糖尿病小鼠的血糖水平、血液学指标、肝酶和胰腺组织结构的影响。结果与讨论:水提取物和乙醇提取物对健康和耐糖小鼠的血糖水平无影响(P>0.05)。甲醇提取物可降低健康小鼠的血糖(P<0.05),但对耐糖小鼠在给药后3h的血糖无影响(P>0.05)经过21天的研究,服用甲醇和乙醇提取物的糖尿病小鼠血糖水平分别下降了45.67%和40.33%。在研究的21天内,水提取物和格列齐特(10 mg/kg)对糖尿病小鼠的血糖水平没有降低作用。甲醇和乙醇提取物都能有效调节糖尿病小鼠的肝脏酶水平。在未治疗和治疗的糖尿病小鼠中,胰岛结构均因β细胞变性而退化,出现间隙。结论:乙醇提取物在调节血糖水平方面具有潜在的应用前景。
{"title":"Potential use of <i>Balanophora latisepala</i> (V. Tiegh.) Lec. extract for the treatment of diabetes.","authors":"Nguyen Trong Hong Phuc, Nguyen Thi Yen Lan, Nguyen Van Ay","doi":"10.4103/ijp.ijp_253_23","DOIUrl":"10.4103/ijp.ijp_253_23","url":null,"abstract":"<p><strong>Introduction: </strong>Balanophora latisepala (BL) is a chlorophyll-free and obligate parasitic plant found across mountainous areas of An Giang, Vietnam. This study was conducted to evaluate the effectiveness of extracts from BL, herbs mentioned in many traditional medicines in the treatment of diabetes, on laboratory mice.</p><p><strong>Materials and methods: </strong>The effects of BL aqueous, methanol, and ethanol extracts on the blood glucose levels, hematological indices, liver enzymes, and pancreatic tissue structure of normal, glucose-tolerant mice, and diabetic mice treated with streptozotocin (STZ) were assessed. Mice were orally administered extracts at a concentration of 500 mg/kg.</p><p><strong>Results and discussion: </strong>The aqueous and ethanol extracts did not affect the blood glucose levels of healthy and glucose-tolerant mice (P > 0.05). The methanol extract reduced the blood glucose of healthy mice (P < 0.05) but did not affect the blood glucose of glucose-tolerant mice 3 h after administration (P > 0.05). When taking the methanol and ethanol extracts, the diabetic mice experienced a 45.67% and a 40.33% decrease in blood glucose levels after 21 days of research, respectively. Aqueous extract and gliclazide (10 mg/kg) showed no effect on reducing blood glucose levels in diabetic mice over the 21 days of the study. Both methanol and ethanol extracts were effective in regulating liver enzyme levels in diabetic mice. In both untreated and treated diabetic mice, pancreatic islet structures were degraded with the appearance of gaps resulting from β-cell degeneration.</p><p><strong>Conclusion: </strong>This implies that ethanol extracts have potential applications in regulating blood glucose levels.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"55 4","pages":"237-242"},"PeriodicalIF":2.4,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657624/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41113817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Pharmacology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1